Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease

Genetic Testing

Volumn 3, Issue 1, 1999, Pages 55-63

  Koenig, Barbara A ^a,b   Silverberg, Heather L ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; GENETIC COUNSELING; GENETIC PREDISPOSITION; HUMAN; MEDICAL ETHICS; PRENATAL DIAGNOSIS; REVIEW; RISK ASSESSMENT;

EID: 0032965845     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1999.3.55     Document Type: Review

References (46)

1. BALSHEM, M.L. (1993). Cancer in the Community: Class and Medical Authority. (Smithsonian Institution Press, Washington, DC) pp. xviii, 174.
2. BERNSTEIN, P.L. (1996). Against the Gods: The Remarkable Story of Risk. (John Wiley & Sons, New York).
3. COLLINS, F.S. (1997). Preparing health professionals for the genetic revolution [editorial]. J. Am. Med. Assn. 278, 1285-1286.
4. COTE, G. (1982). Odds in genetic counseling. J. Med. Genet. 19, 455-457.
5. DAVISON, C., SMITH, G.D., and FRANKEL, S. (1991). Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Socio Health & Illness 13, 1-19.
6. DOUGLAS, M. (1985). Risk Acceptability According to the Social Sciences. (Russell Sage Foundation, New York).
7. DOUGLAS, M., and WILDAVSKY, A.B. (1982). Risk and Culture: An Essay on the Selection of Technical and Environmental Dangers. (University of California Press, Berkeley) pp. ix, 221.
8. EGAN, K.M., NEWCOMB, P.A., LONGNECKER, M.P., et al. (1996). Jewish religion and risk of breast cancer. Lancet 347, 1645-1646.
9. FISCHOFF, B., SLOVIC, P., and LICHENSTEIN, S. 1979. Subjective sensitivity analysis: Organizational behavior and human performance. Organ. Behav. Hum. Decision Proc. 23(3), 339-359.
10. FOX, P.J., KELLY, S.E., and TOBIN, S.L. (1999). Defining dementia: Social and historical background of Alzheimer disease. Genet. Testing 3, 13-19.
11. GORDON, D.R. (1988). Clinical science and clinical expertise: Redefining boundaries between art and science in medicine. In Biomedicine Examined. M. Lock and D.R. Gordon (eds.). (D. Reidel, Dordrecht, Holland).
12. HYMAN, B.T. (1996). Apolipoprotein E geneotype: Utility in clinical practice in Alzheimer's Disease [see comment]. J. Amer. Geriat. Soc. 44, 1469-1471.
13. JOU, J., SHANTEAU, J., and HARRIS, R. (1996). An information processing view of framing effects: The role of causal schemas in decision making. Mem. Cognit. 24, 1-15.
14. KAVANAGH, A., and BROOM, D. (1998). Embodied risk: my body, myself? Soc. Sci. Med. 46, 437-444.
15. KESSLER, S., and LEVINE, E.K. (1987). Psychological aspects of genetic counseling. IV. The subjective assessment of probability. Am. J. Med. Genet. 28, 361-370.
16. KHOURY, M.J. (1996). From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group [see comments]. Am. J. Public Health 86, 1717-1722.
17. KOLATA, G. (1998). Genetic testing falls short of public embrace. The New York Times, March 27, 1998.
18. LAMBERT, H., and ROSE, H. (1996). Disembodied Knowledge? Making Sense of Medical Science. In Misunderstanding Science? The Public Reconstruction of Science and Technology. A. Irwin, (ed.) Cambridge University Press, Cambridge.
19. LERMAN, C., KASH, K., and STEFANEK, M. (1994). Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J. Nat. Cancer Inst. Monogr. 16, 171-176.
20. LERMAN, C., LUSTBADER, E., RIMER, B., et al. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. J. Natl. Cancer Inst. 87, 286-292.
21. LICHENSTEIN, S., and NEWMAN, J.R. 1967. Empirical scaling of common verbal phrases associated with numerical probabilities. Psychonomic Science 9(10), 563-564.
22. LIPPMAN-HAND, A., and FRASER, F.C. (1979). Genetic counseling: Provision and reception of information. Am. J. Med. Genet. 3, 113-127.
23. LOWRANCE, W.W. (1976). Acceptable Risk: Science and the Determination of Safety. (W. Kaufmann, Los Altos, CA).
24. MARTEAU, T.M. (1989). Framing of information: Its influence upon decisions of doctors and patients. Br. J. Soc. Psychol. 28, 89-94.
25. McCONNELL, L.M., KOENIG, B.K., GREELY, H.T., et al. (1999a). Genetic testing and Alzheimer disease: Recommendations of the Stanford Program in Genomics, Ethics, and Society. Genet. Testing 3, 3-12.
26. McCONNELL, L.M., SANDERS, G., and OWENS, D.K. (1999b). Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease. Genet. Testing 3, 47-53.
27. McNEIL, B.J., PAUKER, S.G., SOX, H.C., JR., and TVERSKY, A. (1982). On the elicitation of preferences for alternative therapies. N. Engl. J. Med. 306, 1259-1262.
28. NATIONAL CANCER INSTITUTE. (1988). How the public perceives, processes, and interprets risk information: findings from focus group research with the general public. National Cancer Institute Office of Cancer Communications, Bethesda.
29. NATIONAL COUNCIL ON AGING. (1997). Myths and misperceptions about aging and women's health. (Washington, DC).
30. NELKIN, D., and LINDEE, M.S. (1997). The revival of eugenics in American popular culture. J. Am. Med. Womens Assoc. 52, 45-46.
31. PARSONS, E.P., and CLARKE, A.J. (1993). Genetic risk: Women's understanding of carrier risks in Duchenne muscular dystrophy. J. Med. Genet. 30, 562-566.
32. PEARN, J.H. (1973). Patients' subjective interpretation of risks offered in genetic counselling. J. Med. Genet. 10, 129-134.
33. PRESS, N., and KOENIG, B. Graphing Uncertainty: The Presentation and Representation of Individualized Risk for Breast Cancer. Abstract and oral paper, Annual Meetings of the American Anthropological Association, San Francisco.
34. REDELMEIER, D.A., and TVERSKY, A. (1990). Discrepancy between medical decisions for individual patients and for groups. N. Engl. J. Med. 322, 1162-1164.
35. SCHONE-SEIFERT, B. (1995). Risk. In Encyclopedia of Bioethics. W.T. Reich (ed.) (Simon & Schuster Macmillan, New York) pp. 2316-2321.
36. SESHADRI, A., DRACHMAN, D.A., and LIPPA, C.F. (1995). Apolipoprotein E e4 allele and the lifetime risk of Alzheimer's disease. Arch. Neurol. 52, 1074-1079.
37. SHILOH, S., and BERKENSTADT, M. (1992). Lay conceptions of genetic disorders. Birth Defects Orig. Artic. Ser. 28, 191-200.
38. SHILOH, S., and SAGI, M. (1989). Effect of framing on the perception of genetic recurrence risks. Am. J. Med. Genet. 33, 130-135.
39. STROHMAN, R.C. (1993). Ancient genomes, wise bodies, unhealthy people: Limits of a genetic paradigm in biology and medicine. Perspect. Biol. Med. 37, 112-145.
40. TURNEY, J. (1995). The Public Understanding of Genetics - Where Next? Eur. J. Genet. Soc., 1, 5-20.
41. TURNEY, J. (1996). Public understanding of science. Lancet 347, 1087-1090.
42. TVERSKY, A., and KAHNEMAN, D. (1974). Judgement under uncertainty: heuristics and biases. Science 185, 1124-1130.
43. TVERSKY, A., and KAHNEMAN, D. (1981). The framing of decisions and the psychology of choice. Science 211, 453-458.
44. WELCH, H.G., and BURKE, W. (1998). Uncertainties in genetic testing for chronic disease. J. Am. Med. Assn. 280, 1525-1527.
45. WERTZ, D.C., SORENSON, J.R., and HEEREN, T.C. (1984). Genetic counseling and reproductive uncertainty. Am. J. Med. Genet. 18, 79-88.
46. WEXLER, A. (1995). Mapping Fate: A Memoir of Family, Risk, and Genetic Research. (Times Books, New York).